Tong QS - Search Results

1

A Tumor-Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer.

Tong QS, Miao WM, Huang H, Luo JQ, Liu R, Huang YC, Zhao DK, Shen S, Du JZ, Wang J. Tong QS, et al. Small. 2021 Jul;17(29):e2101208. doi: 10.1002/smll.202101208. Epub 2021 Jun 18. Small. 2021. PMID: 34145747

2

Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy.

Huang H, Jiang CT, Shen S, Liu A, Gan YJ, Tong QS, Chen SB, Gao ZX, Du JZ, Cao J, Wang J. Huang H, et al. Among authors: tong qs. Nano Lett. 2019 Aug 14;19(8):5356-5365. doi: 10.1021/acs.nanolett.9b01807. Epub 2019 Jul 12. Nano Lett. 2019. PMID: 31286779

3

Angiopep-2 conjugated nanoparticles loaded with doxorubicin for the treatment of primary central nervous system lymphoma.

Shi XX , Miao WM , Pang DW , Wu JS , Tong QS , Li JX , Luo JQ , Li WY , Du JZ , Wang J . Shi XX , et al. Among authors: tong qs. Biomater Sci. 2020 Mar 7;8(5):1290-1297. doi: 10.1039/c9bm01750j. Epub 2020 Jan 3. Biomater Sci. 2020. PMID: 31899467

4

Nanoparticle-Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage-Mediated Cancer Immunotherapy.

Zhang YR, Luo JQ, Zhang JY, Miao WM, Wu JS, Huang H, Tong QS, Shen S, Leong KW, Du JZ, Wang J. Zhang YR, et al. Among authors: tong qs. Small. 2020 Nov;16(46):e2004240. doi: 10.1002/smll.202004240. Epub 2020 Oct 26. Small. 2020. PMID: 33107142

5

Therapeutic Nanocarriers Inhibit Chemotherapy-Induced Breast Cancer Metastasis.

Li T, Akinade T, Zhou J, Wang H, Tong Q, He S, Rinebold E, Valencia Salazar LE, Bhansali D, Zhong Y, Ruan J, Du J, Dalerba P, Leong KW. Li T, et al. Adv Sci (Weinh). 2022 Nov;9(33):e2203949. doi: 10.1002/advs.202203949. Epub 2022 Oct 11. Adv Sci (Weinh). 2022. PMID: 36220339 Free PMC article.

6

Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer.

Huang CZ, Zhou Y, Tong QS, Duan QJ, Zhang Q, Du JZ, Yao XQ. Huang CZ, et al. Among authors: tong qs. Biomaterials. 2022 Nov;290:121827. doi: 10.1016/j.biomaterials.2022.121827. Epub 2022 Sep 27. Biomaterials. 2022. PMID: 36228517

7

Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.

Li JX, Shu N, Zhang YJ, Tong QS, Wang L, Zhang JY, Du JZ. Li JX, et al. Among authors: tong qs. ACS Appl Mater Interfaces. 2024 May 22;16(20):25665-25675. doi: 10.1021/acsami.4c01563. Epub 2024 May 12. ACS Appl Mater Interfaces. 2024. PMID: 38735053

8

PAMAM-Based Polymeric Immunogenic Cell Death Inducer To Potentiate Cancer Immunotherapy.

Huang H, Tong QS, Chen Y, Liu XY, Liu R, Shen S, Du JZ, Wang J. Huang H, et al. Among authors: tong qs. J Am Chem Soc. 2024 Oct 23;146(42):29189-29198. doi: 10.1021/jacs.4c11636. Epub 2024 Oct 10. J Am Chem Soc. 2024. PMID: 39387453

9

A size-switchable nanocluster remodels the immunosuppressive microenvironment of tumor and tumor-draining lymph nodes for improved cancer immunotherapy.

Tong QS, Huang H, Yu HH, Liu R, Shen S, Du JZ. Tong QS, et al. Biomaterials. 2025 Apr;315:122910. doi: 10.1016/j.biomaterials.2024.122910. Epub 2024 Oct 22. Biomaterials. 2025. PMID: 39467399

10

Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions.

Li HJ, Fang EH, Wang JQ, Zheng LD, Tong QS. Li HJ, et al. Among authors: tong qs. Curr Med Sci. 2020 Feb;40(1):95-103. doi: 10.1007/s11596-020-2151-y. Epub 2020 Mar 13. Curr Med Sci. 2020. PMID: 32166670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters